Emerging therapies for neurological and neurodegenerative diseases: From lab to life

Neurologic disorders, which include neurological troubles and mental diseases, represent a major burden on public health, costing economies billions of dollars every year. The clinical expression of neurologic diseases is very heterogeneous and the underlying causes are also very diverse, including head and spinal malformations, infection, vascular or traumatic damage, metabolic alterations, and neurodegeneration. While some neurologic conditions are congenital, the majority of them occur later in life. Neurologic illnesses affect people from all age ranges, from infants with congenital disorders to adults with stroke or tumors, and patients with neurocriptopathies such as Alzheimer’s disease, Parkinson’s disease, and prion disease.